Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,817 | 7,442 | 5,546 | 4,108 | 4,569 |
| Receivables | 12,109 | 11,937 | 13,479 | 14,866 | 12,831 |
| Inventories | 21,604 | 22,255 | 22,816 | 23,245 | 25,990 |
| Other current assets | 3,275 | 3,335 | 3,061 | 2,898 | 3,401 |
| TOTAL | $43,805 | $44,969 | $44,902 | $45,117 | $46,791 |
| Non-Current Assets | |||||
| PPE Net | 4,990 | 4,913 | 5,009 | 5,106 | 5,221 |
| Intangibles | 17,904 | 19,291 | 19,090 | 67,456 | 69,780 |
| Other Non-Current Assets | 11,293 | 10,920 | 10,800 | 8,965 | 9,447 |
| TOTAL | $34,187 | $35,124 | $34,899 | $81,527 | $84,448 |
| Total Assets | $77,992 | $80,093 | $79,801 | $126,644 | $131,239 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 33,967 | 34,864 | 35,958 | 36,956 | 3,606 |
| Accounts payable and accrued liabilities | 5,176 | 4,722 | 4,808 | 4,787 | 5,283 |
| Other current liabilities | 15,253 | 15,616 | 14,837 | 13,215 | 13,862 |
| TOTAL | $54,396 | $55,202 | $55,603 | $54,958 | $22,751 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 34,252 |
| Other Non-Current Liabilities | 8,795 | 8,424 | 8,646 | 7,636 | 8,207 |
| TOTAL | $9,528 | $9,158 | $9,363 | $8,346 | $43,166 |
| Total Liabilities | $63,924 | $64,360 | $64,966 | $63,304 | $65,917 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,580 | 44,531 | 44,214 | 44,074 | 43,617 |
| Common Shares | 446 | 445 | 442 | 441 | 436 |
| Retained earnings | -211,863 | -210,632 | -208,350 | -158,010 | -158,028 |
| Other shareholders' equity | -12,437 | -11,702 | -14,361 | -15,670 | -13,059 |
| TOTAL | $14,068 | $15,733 | $14,835 | $63,340 | $65,322 |
| Total Liabilities And Equity | $77,992 | $80,093 | $79,801 | $126,644 | $131,239 |